
Purchase 3-HO-PCE
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 3-HO-PCE for sale
3-HO-PCE is a novel synthetic dissociative of the arylcyclohexylamine chemical class, which produces potent, dose-sensitive dissociative, hallucinogenic and euphoric effects when administered. Unlike its close structural analogue, 3-HO-PCP, this compound had no precedent in the scientific literature before being offered on the research chemicals market in the 2010s.
3-HO-PCE is a novel synthetic dissociative of the arylcyclohexylamine chemical class. When administered, it acts as an NMDA receptor antagonist and produces potent, dose-sensitive dissociative, hallucinogenic, and euphoric effects.
3-HO-PCE is a novel synthetic dissociative of the arylcyclohexylamine chemical class, which produces potent, dose-sensitive dissociative, hallucinogenic, and euphoric effects when administered.
3-HO-PCE (Known on the street as Cloud 9) is a novel synthetic dissociative of the arylcyclohexylamine chemical class which produces potent, dose-sensitive dissociative, hallucinogenic and euphoric effects when administered. It is used recreationally for its dissociative and hallucinogenic effects.
3-HO-PCE, or 3-hydroxy-piperidine-1-carbonyl-ethyl-amine, is a synthetic drug with no precedent in the scientific literature before being offered on the research chemicals market.
3-(2-Chlorophenyl)-1-(1-pyrolidinyl)-cyclohexan-1-one (also known as 3-HO-PCE) is a synthetic drug of the dissociative class. It works primarily via NMDA receptor antagonism.
3-HO-PCE (known as 3-Hydroxyeticyclidine) is a novel synthetic dissociative substance of the arylcyclohexylamine chemical class.
3-HO-PCE is a novel synthetic dissociative substance of the arylcyclohexylamine chemical class. It produces potent, dose-sensitive dissociative, hallucinogenic and euphoric effects when administered.
3-HO-PCE is a novel synthetic hallucinogenic substance of the arylcyclohexylamine chemical class. It is thought to produce dissociative, hallucinogenic and euphoric effects when administered.
3-HO-PCE is a novel synthetic dissociative substance of the arylcyclohexylamine chemical class and has become widely used as a recreational drug. It produces potent dissociative, hallucinogenic and euphoric effects when administered, acting as a prodrug to 3- hydroxy-PCE.
3-HO-PCE, commonly known as HOP, is a novel synthetic dissociative substance of the arylcyclohexylamine chemical class and has become a recreational drug.
3-HO-PCE, commonly referred to as 3-HO-PCP or PCP-3, is a synthetic dissociative drug and psychostimulant. It is in the arylcyclohexylamine chemical class and has gained popularity since its release in late 2014.
3-HO-PCE is a novel synthetic dissociative drug of the arylcyclohexylamine class.
3-HO-PCE, 3-Hydroxy-1-(2-phenylmethyl)-4-(n)-butoxybenzene, a compound that is relatively little known but holds great promise as a powerful new synthetic dissociative.
3-HO-PCE is a novel synthetic drug of the dissociative class. Reports indicate it produces intense hallucinogenic effects at high dosages.
When administered, a novel substance first synthesized by Alexander Shulgin, 3-HO-PCE, produces potent hallucinogenic effects. It is part of a series of psychoactive substances whose chemical structure contains a cathinone group.
3-HO-PCE, or 3-hydroxyeticyclidine, is a phenylpiperidine derivative with similar effects to PCP. These include euphoria, auditory and visual hallucinations and disorganized thinking. In contrast to PCP, 3-HO-PCE causes only mild nausea at high doses, although, as with all dissociatives, it can also cause muscle spasms and convulsions, leading to death in overdoses.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
1kg $1690
100g $490
500g $1390
1kg $1690
1kg $1690
1kg $1690
100g $390
1kg $1590
100g $510
500g $1080
1kg $1690
100g $510